Key result
Eight macrophage-localized anoikis genes identify atherosclerosis with diagnostic AUCs exceeding 0.83.
Why the study?
The involvement of anoikis resistance in immune-cell persistence and plaque progression in atherosclerosis remains poorly understood.
Answers are grounded in this paper and cite their sources.
This multi-omics and experimental study identifies a macrophage-centered anoikis-related 8-gene signature—highlighted by HAVCR2—associated with foam cell and inflammatory macrophage states in atherosclerosis.
Background Atherosclerosis (AS) is a chronic inflammatory vascular disease characterized by immune dysregulation, metabolic disturbance, and progressive vascular remodeling. Although anoikis resistance has been extensively investigated in cancer biology, its involvement in immune-cell persistence and plaque progression in AS remains poorly understood. Methods We integrated two publicly available bulk transcriptomic datasets (GSE100927 and GSE28829) to identify differentially expressed genes (DEGs) and performed weighted gene co-expression network analysis (WGCNA) to determine disease-associated gene modules. Anoikis-related candidate genes were obtained by intersecting DEGs, WGCNA-derived module genes, and a curated anoikis-related gene set, and were further prioritized using least absolute shrinkage and selection operator (LASSO) regression and random forest algorithms. Immune infiltration and cell type–specific expression patterns were evaluated using CIBERSORT and single-cell RNA sequencing (scRNA-seq) analyses. The expression of the leading candidate was validated using both in vitro and in vivo experiments. Results We identified eight core anoikis-related hub genes—HAVCR2, CD36, PLAU, TNF, PYCARD, SERPINA1, BLNK, and CHI3L1—that were closely associated with AS. These genes were enriched in inflammatory and metabolic pathways and showed strong diagnostic performance across validation analyses, with AUC values greater than 0.83. Immune deconvolution and single-cell transcriptomic analyses revealed that the anoikis-related signature was predominantly localized to macrophage and T-cell compartments within atherosclerotic lesions. Among the identified candidates, HAVCR2 showed the most consistent disease-associated pattern. HAVCR2 expression was markedly increased in oxLDL-stimulated THP-1-derived macrophages and was enriched in macrophage-rich atherosclerotic lesions in high-fat diet–fed ApoE −/− mice, supporting its association with lipid-induced macrophage activation and vascular inflammation. Conclusion This study defines a macrophage-centered anoikis-related immune signature in atherosclerosis and identifies HAVCR2, together with CD36, PLAU, TNF, PYCARD, SERPINA1, BLNK, and CHI3L1, as potential biomarkers and candidate targets for future diagnostic and therapeutic investigation.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2026) studied Atherosclerosis (n=12). High-fat, high-cholesterol diet (in vivo) / oxLDL stimulation (in vitro) / Anoikis-related hub gene signature (HAVCR2, CD36, PLAU, TNF, PYCARD, SERPINA1, BLNK, CHI3L1) vs. Normal chow diet (mice); untreated control macrophages; non-atherosclerotic/early plaque reference tissues was evaluated on Diagnostic performance (AUC) of the 8 anoikis-related hub genes for atherosclerosis and HAVCR2 expression validation (AUC > 0.83 (external validation for HAVCR2: AUC 0.833)). Eight anoikis-related hub genes (including HAVCR2) localized to plaque macrophages and demonstrated diagnostic performance for atherosclerosis with AUC values > 0.83.
Synapse has enriched 10 related papers. Consider them for comparative context: